Machine Learning and AI in Cancer Prognosis, Prediction, and Treatment Selection: A Critical Approach
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
Cancer is a leading cause of morbidity and mortality worldwide. While progress has been made in the diagnosis, prognosis, and treatment of cancer patients, individualized and data-driven care remains a challenge. Artificial intelligence (AI), which is used to predict and automate many cancers, has emerged as a promising option for improving healthcare accuracy and patient outcomes. AI applications in oncology include risk assessment, early diagnosis, patient prognosis estimation, and treatment selection based on deep knowledge. Machine learning (ML), a subset of AI that enables computers to learn from training data, has been highly effective at predicting various types of cancer, including breast, brain, lung, liver, and prostate cancer. In fact, AI and ML have demonstrated greater accuracy in predicting cancer than clinicians. These technologies also have the potential to improve the diagnosis, prognosis, and quality of life of patients with various illnesses, not just cancer. Therefore, it is important to improve current AI and ML technologies and to develop new programs to benefit patients. This article examines the use of AI and ML algorithms in cancer prediction, including their current applications, limitations, and future prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The number of new cancer cases reported in 2020 and the number of deaths caused by these cancers. (A). Estimated number of new cases worldwide in 2020 among both sexes. (B) Estimated number of deaths worldwide in 2020 among both sexes. Reprinted from World Health Organization. © International Agency for Research on Cancer, 2020. Cancer Today. Available from:https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=total&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0. [Accessed June 20, 2023].4](https://figures.cochat.ai/paper-figures/4b0ab44029a44f16a12f5635c58c3a2b/machine-learning-and-ai-in-cancer-prognosis-prediction-and-treatment-selection-a-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These techniques have been applied to predict cancer prognosis and estimate treatment response based on genomic and clinical data [8–14].”
From Integrating machine learning and artificial intelligence in life-course epidemiology: pathways to innovative public health solutions (2024) · cites this paper as [10]
In the citing paper
“Research by Kumar et al. (76) and Zhang et al. (77) examined the use of AI algorithms in cancer and diagnosis. The studies revealed that AI algorithms achieved high accuracy rates in diagnosing cancer subtypes, assisting clinicians in developing tailored treatment plans.”
From Improving health literacy using the power of digital communications to achieve better health outcomes for patients and practitioners. (2023) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Research on Early Warning Mechanism and Model of Liver Cancer Rehabilitation Based on CS-SVM
Bo, J., Shuang, L., Ma, P., Zhu, Y., & Zhang, Y. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/6658776 · Cited by 17 · cited 1×
“14 Studies have also reported that different ML and AI techniques serve as models for global practices allowing big data and cognition-capable computers to aid cancer research specialists in revolutionizing medicine by performing multifaceted tasks to improve clinical workflow, diagnostic accuracy,…”
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 2×
“3 million new cases and 10 million deaths have been reported annually.(2) Lung cancer remains the most common cause of cancer-related mortality, with expected 1.”
BackgroundThe FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423 · cited 1×
“84 An editorial has been published which is based on the challenges of the effectual implementation of FAIR Principles in biomedical research.”
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362 · cited 1×
“Recently, ML algorithms have been used successfully in prognosis of skin cancer with equivalent accuracy to a skilled dermatologist, 24 and to predict the development of pre-diabetes type 2 diabetes using routinely obtained electronic health record data of the patients.”
Machine learning: Trends, perspectives, and prospects
Jordan, M. I., & Mitchell, T. M. (2015) · Science · doi:10.1126/science.aaa8415 · Cited by 9,955 · cited 1×
“23 To date, the primary benefactors of the twenty-first-century surge in the availability of big data, data science, and machine learning have been companies that were able to acquire these data and pay the required personnel to transform their products.”
Gene selection for cancer classification using support vector machines
Guyon, I., Weston, J., Barnhill, S., & Vapnik, V. (2002) · Machine Learning · doi:10.1023/a:1012487302797 · Cited by 9,954
Santos, A. G., da Rocha, G. O., & de Andrade, J. B. (2019) · Scientific Reports · doi:10.1038/s41598-018-37186-2 · Cited by 8,495
Knowledge Graph Embedding by Translating on Hyperplanes
Wang, Z., Zhang, J., Feng, J., & Chen, Z. (2014) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v28i1.8870 · Cited by 3,915
International evaluation of an AI system for breast cancer screening
McKinney, S. M., Sieniek, M., Godbole, V., Godwin, J., Antropova, N., Ashrafian, H., Back, T., Chesus, M., Corrado, G. S., Darzi, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1799-6 · Cited by 3,287 · cited 1×
“” In January 2020, researchers developed an artificial intelligence system based on a “Google DeepMind algorithm” capable of outperforming human “breast cancer” detection specialists.(36,37) In July 2020, the University of Pittsburgh developed an AI systembased machine learning technique with the highest accuracy in d…”
MethodA Survey on Knowledge Graphs: Representation, Acquisition, and Applications
Ji, S., Pan, S., Cambria, E., Marttinen, P., & Yu, P. S. (2022) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2021.3070843 · Cited by 2,947
Research works printed but not linked: 13
- Kubat M. An Introduction to Machine Learning. Springer; 2017.
- Alpaydin E. Introduction to Machine Learning. MIT press; 2020.
- Rebala G, Ravi A, Churiwala S. An Introduction to Machine Learning. Springer; 2019.
- Ertel W. Introduction to Artificial Intelligence. Springer; 2018.
- Kalis B, Collier M, Fu R. 10 promising AI applications in health care. Harv Bus Rev. 2018; 2018: 1.
- Ray A, Chen M, Gelogo Y. Performance Comparison of Different Machine Learning Algorithms for Risk Prediction and Diagnosis of Breast Cancer. In: Smart Technologies in Data Science and Communication. Springer; 2020: 71– 76.
- Kharya S, Dubey D, Soni S. Predictive machine learning techniques for breast cancer detection. Int J Comput Sci Inf Technol. 2013; 4(6): 1023– 1028.
- Lv Z, Yu Z, Xie S, Alamri A. Deep learning-based smart predictive evaluation for interactive multimedia-enabled smart healthcare. ACM Trans Multimedia Comput Commun Appl. 2022; 18(1): 1– 20.
- Tumuluru P, Ravi B. GOA-based DBN: grasshopper optimization algorithm-based deep belief neural networks for cancer classification. Int J Appl Eng Res. 2017; 12(24): 14218– 14231.
- Sivashanker K, Duong T, Resnick A, Eappen S. Health care equity: from fragmentation to transformation. NEJM Catal Innov Care Deliv. 2020; 1 5.
- Zhang P, Schmidt DC, White J, Lenz G. Chapter One - Blockchain Technology Use Cases in Healthcare. In: Raj P, Deka GC, editors. Advances in Computers. Vol. 111. Elsevier; 2018: 1– 41.
- Stokman FN, de Vries PH. Structuring Knowledge in a Graph. Rijksuniversiteit Groningen; 1986.
- Alawad M, Gao S, Shekar MC, et al. Integration of domain knowledge using medical knowledge graph deep learning for cancer phenotyping. arXiv preprint arXiv. 2021; 2021: 210101337.
Cited by
Fitzpatrick, P. J. (2023) · Frontiers in Digital Health · doi:10.3389/fdgth.2023.1264780 · Cited by 416
Khalighi, S., Reddy, K., Midya, A., Pandav, K. B., Madabhushi, A., & Abedalthagafi, M. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00575-0 · Cited by 306
“AI can add value at all steps of tumor diagnosis, with the majority of ,pathologydata,orbothdatamodescombined 68 .”
AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis
Alum, E. U. (2025) · Discover Oncology · doi:10.1007/s12672-025-02064-7 · Cited by 208
Integrating artificial intelligence in healthcare: applications, challenges, and future directions
Chong, P. L., Vaigeshwari, V., Reyasudin, B. K. M., Hidayah, B. R. A. N., Purnshatman, T., Yeow, J. A., & Kong, F. Y. (2025) · Future Science OA · doi:10.1080/20565623.2025.2527505 · Cited by 132
“Zhang et al. [87] call for transparent frameworks that govern Ai deployment, particularly in high-stakes fields like oncology. to this end, policymakers and healthcare institutions must establish ethical guidelines that address issues such as the secondary use of data, algorithmic bias, and the…”
Vinay, V., Jodalli, P. S., Chavan, M. S., Buddhikot, C. S., Luke, A. M., Ingafou, M., Reda, R., Pawar, A. M., & Testarelli, L. (2025) · Diagnostics · doi:10.3390/diagnostics15030280 · Cited by 95
Ali, M. U., Benfante, V., Basirinia, G., Alongi, P., Sperandeo, A., Quattrocchi, A., Giannone, A. G., Cabibi, D., Yezzi, A. J., Raimondo, D. D., et al. (2025) · Journal of Imaging · doi:10.3390/jimaging11020059 · Cited by 96
“ML utilizes algorithms that learn from the data to identify patterns and features and make predictions without requiring detailed instructions [30–32].”
Prasanthi, S., Kumarachari, R. K., Bukke, S. P. N., Rajasekhar, E. S. K., Ashokkumar, J. A., & Eftekhari, Z. (2025) · Discover Oncology · doi:10.1007/s12672-025-02469-4 · Cited by 100
“Deep learning (DL), a branch of ML, replicates human data processing capabilities to recognize patterns, interpret spoken language, discover novel drugs, advance personalized medicine, refine diagnostic tests, and assist in clinical decision-making [77].”
Artificial intelligence in cancer diagnosis: Opportunities and challenges
Alshuhri, M. S., Al‐Musawi, S. G., Al-Alwany, A. A., Uinarni, H., Rasulova, I., Rodrigues, P., Alkhafaji, A. T., Alshanberi, A. M., Alawadi, A. H., & Abbas, A. H. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154996 · Cited by 89
Chen, S., Yu, J., Chamouni, S., Wang, Y., & Li, Y. (2024) · BMC Medicine · doi:10.1186/s12916-024-03566-x · Cited by 73
Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions
Pham, T. D., Teh, M., Chatzopoulou, D., Holmes, S., & Coulthard, P. (2024) · Current Oncology · doi:10.3390/curroncol31090389 · Cited by 89
Dewaker, V., Morya, V. K., Kim, Y. H., Park, S. T., Kim, H. S., & Koh, Y. H. (2025) · Biomarker Research · doi:10.1186/s40364-025-00764-4 · Cited by 63
Role of artificial intelligence in cancer drug discovery and development
Sarvepalli, S., & Vadarevu, S. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217821 · Cited by 69
Abas Mohamed, Y., Ee Khoo, B., Shahrimie Mohd Asaari, M., Ezane Aziz, M., & Rahiman Ghazali, F. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105689 · Cited by 57
Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 65
Olawade, D. B., David-Olawade, A. C., Adereni, T., Egbon, E., Teke, J., & Boussios, S. (2025) · Diseases · doi:10.3390/diseases13010024 · Cited by 68
Elfatimi, E., Lekbach, Y., Prakash, S., & BenMohamed, L. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1620572 · Cited by 61
“As AI systems continue to integrate biological, clinical, and imaging data, their predictive power will enhance not only vaccine efficacy but also overall treatment precision, ultimately improving patient survival and quality of life (Zhang et al., 2023a).”
InfluentialAdvancing Patient-Centered Shared Decision-Making with AI Systems for Older Adult Cancer Patients
Hao, Y., Liu, Z., Riter, R. N., & Kalantari, S. (2024) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3613904.3642353 · Cited by 62
“While these outputs need to be care-fully reviewed by clinicians, they can incorporate the most up-to-date healthcare information, ensuring that discussions are based on the most current and relevant evidence [106].”
Vyas, A., Kumar, K., Sharma, A., Verma, D., Bhatia, D. D., Wahi, N., & Yadav, A. K. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110178 · Cited by 53
Diagnostic accuracy of large language models in psychiatry
Gargari, O. K., Fatehi, F., Mohammadi, I., Firouzabadi, S. R., Shafiee, A., & Habibi, G. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104168 · Cited by 48
A Comprehensive Review of Screening Methods for Ovarian Masses: Towards Earlier Detection
Sahu, S. A., & Shrivastava, D. (2023) · Cureus · doi:10.7759/cureus.48534 · Cited by 42
Srivastav, A. K., Singh, A., Singh, S., Rivers, B. M., Lillard, J. W., & Singh, R. (2025) · Cancers · doi:10.3390/cancers17172866 · Cited by 41
“In a recent work, Zhang, B. et al. showed that AI models can assess demographic risk factors, healthcare facility distributions, and population-level cancer incidence rates to identify regions with disproportionately high cancer mortality and low screening uptake [23].”
Harnessing the Potential of Artificial Intelligence in Managing Viral Hepatitis
Ali, G., Mijwil, M. M., Adamopoulos, I., Buruga, B. A., Gök, M., & Sallam, M. (2024) · Mesopotamian Journal of Big Data · doi:10.58496/mjbd/2024/010 · Cited by 41
“…on creating computer systems that employ data analysis and pre-programmed instructions to mimic and perform intelligent tasks, such as learning, pattern recognition, natural language understanding, problem-solving, perception, and decision-making that require human intelligence [32][62-64].”
The leading global health challenges in the artificial intelligence era
Zaidan, A. M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1328918 · Cited by 37
“During the analysis phase of patient data, AI can identify the early signs of the differentiate between cancerous and normal tissues (56, 57).”
Predicting hepatocellular carcinoma survival with artificial intelligence
Seven, İ., Bayram, D., Arslan, H., Köş, F. T., Gümüşlü, K., Esen, S. A., Sahin, M. Ö., Şendur, M. A. N., & Uncu, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-90884-6 · Cited by 36
Garg, P. K., Krishna, M., Kulkarni, P., Horne, D. A., Salgia, R., & Singhal, S. S. (2025) · Cancers · doi:10.3390/cancers17172799 · Cited by 29
“The sections below discuss the applicable use of ML in forecasting each of these cancers, including the nature of the data, the algorithm being employed, and their clinical value [3,50,58].”
Exploring Extravasation in Cancer Patients
Pham, T. D., & Tsunoyama, T. (2024) · Cancers · doi:10.3390/cancers16132308 · Cited by 33
Bhatt, J., Jain, S., Gupta, S. K., & Bhatia, D. D. (2025) · Nanoscale Advances · doi:10.1039/d5na00390c · Cited by 27
Hormaty, S., Seiwan, A. N., Rasheed, B. H., Parvaz, H., Gharahzadeh, A., & Ghaznavi, H. (2025) · Cancer Medicine · doi:10.1002/cam4.71224 · Cited by 33
“In healthcare, particularly oncology, ML revolutionizes cancer prediction, diagnosis, and treatment [99, 100].”
Extracellular Vesicles and Artificial Intelligence: Unique Weapons against Breast Cancer
Serretiello, E., Smimmo, A., Ballini, A., Parmeggiani, D., Agresti, M., Bassi, P., Moccia, G., Sciarra, A., Angelis, A. D., Monica, P. D., et al. (2024) · Applied Sciences · doi:10.3390/app14041639 · Cited by 26
“…lives, from smart watches that use AI to recognize motor activity to online shopping sites that suggest products based on previous purchasers’ records, but artificially intelligent systems have also made a great contribution to healthcare for patients’ diagnosis, prognosis, and care [148,149].”
BackgroundAswathy, R., & Sumathi, S. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01124-7 · Cited by 29
“The results of AI integration are promising, particularly for women residing in LMICs [5, 6].”
The impact of AI on modern oncology from early detection to personalized cancer treatment
Li, J., Zhang, L., Yu, Z., Bao, Z., Li, D., & Wang, L. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01276-6 · Cited by 24
“Given that the normal clinical course of a cancer patient identi fi es multiple crucial phases where AI systems can offer signi fi cant advantages, ML and DL present a variety of opportunities to improve cancer imaging 98,108 .”
Artificial Intelligence and Cancer Health Equity: Bridging the Divide or Widening the Gap
Dankwa‐Mullan, I., Ndoh, K., Akogo, D., Rocha, H. A. L., & Juaçaba, S. F. (2025) · Current Oncology Reports · doi:10.1007/s11912-024-01627-1 · Cited by 25
“For example, CNNs have been used to identify breast cancer in mammograms with accuracy comparable to, and sometimes exceeding, that of experienced radiologists [4, 13].”
Lin, Y., Ding, J. L., Shen, H.-T., Lin, Y.-M., Adhidjaja, E. C., & Chang, S. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09105-7 · Cited by 25
“It can also aid in predicting treatment outcomes by analyzing pathology profiles and imaging studies [147].”
Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges
Wang, M., Chang, W., & Zhang, Y. (2025) · MedComm · doi:10.1002/mco2.70460 · Cited by 24
Lippi, L., Alessandro de, S. I. R. E., Folli, A., Turco, A., Moalli, S., Marcasciano, M., Ammendolia, A., & Invernizzi, M. (2024) · Cancers · doi:10.3390/cancers16030521 · Cited by 29
“Artificial intelligence (AI) has shown promising potential in improving cancer treat-ment for patients, offering more personalized and effective care [122,123].”
BackgroundVeeraraghavan, V. P., Daniel, S., Dasari, A. K., Aileni, K. R., Patil, C., & Patil, S. R. (2024) · Oral Oncology Reports · doi:10.1016/j.oor.2024.100591 · Cited by 25
Wyatt, L. S., van Karnenbeek, L. M., Wijkhuizen, M., Geldof, F., & Dashtbozorg, B. (2024) · Applied Sciences · doi:10.3390/app14188108 · Cited by 24
van der Heijden, T. G. W., de Ligt, K. M., Hubel, N. J., van der Mierden, S., Holzner, B., van de Poll-Franse, L. V., de Rooij, B. H., & the EORTC Quality of Life Group (2024) · Quality of Life Research · doi:10.1007/s11136-024-03820-y · Cited by 21
“This may be explained by the recent increase in volume of available HRQoL data needed for AI-predic-tions and the general shift in focus towards AI and exploring AI opportunities [123].”
Diagnostics of Thyroid Cancer Using Machine Learning and Metabolomics
Kuang, A., Kouznetsova, V. L., Kesari, S., & Tsigelny, I. F. (2023) · Metabolites · doi:10.3390/metabo14010011 · Cited by 21
“Researchers say that ML helps with diagnostics through analyzing pathology profiles and clinical images and converting data into algorithmic sequences [17].”
BackgroundSacca, L., Lobaina, D., Burgoa, S., Lotharius, K. C., Moothedan, E., Gilmore, N., Xie, J. F., Mohler, R., Scharf, G., Knecht, M. K., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092525 · Cited by 21
“AI techniques and models can be applied in cancer prevention and management by using patient history, scans, imaging information, and analysis of specific genes for cancer classification to reduce overdiagnosis and overtreatment [21,22].”
BackgroundArtificial Intelligence and Breast Cancer Management: From Data to the Clinic
Feng, K., Yi, Z., & Xu, B. (2025) · Cancer Innovation · doi:10.1002/cai2.159 · Cited by 22
“ML encompasses a compilation of intricate algorithms that can effectively handle tasks arising from exponentially growing data by acquiring patterns through iterative processes, resulting in enhanced performance over time [3, 4].”
Bridging technology and medicine: artificial intelligence in targeted anticancer drug delivery
Khorsandi, D., Farahani, A., Zarepour, A., Khosravi, A., Iravani, S., & Zarrabi, A. (2025) · RSC Advances · doi:10.1039/d5ra03747f · Cited by 23
Huang, B., Chen, Q., Ye, Z., Zeng, L., Huang, C., Xie, Y., Zhang, R., & Shen, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713175 · Cited by 18
“ICIs are a novel class of therapeutics that offer significant survival benefits.”
BackgroundInfluentialDevi, R. V., & Keidar, M. (2023) · Applied Sciences · doi:10.3390/app14010355 · Cited by 20
Prediction of acute methanol poisoning prognosis using machine learning techniques
Rahimi, M., Hosseini, S. M., Mohtarami, S. A., Mostafazadeh, B., Evini, P. E. T., Fathy, M., Kazemi, A., Khani, S., Mortazavi, S. M. J., Soheili, A., et al. (2024) · Toxicology · doi:10.1016/j.tox.2024.153770 · Cited by 18
Ong, W., Lee, A., Tan, W. C., Fong, K. T. D., Lai, D. D., Tan, Y. L., Low, X. Z., Ge, S., Makmur, A., Ong, S. J., et al. (2024) · Cancers · doi:10.3390/cancers16172988 · Cited by 21
“However, manual outlining often proves time-consuming and susceptible to variability between observers.”
BackgroundBenmokhtar, S., Laraqui, A., Hilali, F., Bajjou, T., Zaitouni, S. E., Jafari, M., Baba, W., Elannaz, H., Lahlou, I. A., Chahdi, H., et al. (2024) · Clinical Medicine Insights Oncology · doi:10.1177/11795549241255651 · Cited by 21
“132 The clinical implications of RAS and BRAF mutations in CRC patients in the Middle East are significant.”
BackgroundArtificial Intelligence in the Diagnosis of Onychomycosis—Literature Review
Bulińska, B., Mazur-Milecka, M., Sławińska, M., Rumiński, J., & Nowicki, R. J. (2024) · Journal of Fungi · doi:10.3390/jof10080534 · Cited by 18
“In radiology, it is used to analyze medical images, such as X-rays, CT scans, and MRIs [13,14] to detect abnormalities and assist in the diagnosis of conditions like cancer [15] and cardiovascular diseases [16].”
MethodA critical assessment of artificial intelligence in magnetic resonance imaging of cancer
Wu, C., Andaloussi, M. A., Hormuth, D. A., Lima, E. A. B. F., Lorenzo, G., Stowers, C. E., Ravula, S., Levac, B., Dimakis, A. G., Tamir, J. I., et al. (2025) · npj Imaging · doi:10.1038/s44303-025-00076-0 · Cited by 22
“…practical deployment in the clinical setting Although AI-based approaches have demonstrated greater performance over standard clinical information in some settings, these studies are typically done in speci fi c cohorts with limited external validation and therefore havelimitedgeneralizability 115 .”
Loaiza‐Bonilla, A., Thaker, N. G., Chung, C. D., Parikh, R. B., Stapleton, S., & Borkowski, P. (2025) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk-25-100048 · Cited by 21
Taha, B. A., Sulaiman, G. M., Addie, A. J., Khalil, K., Ahmed, E. M., Chaudhary, V., & Arsad, N. (2025) · Methods · doi:10.1016/j.ymeth.2025.06.005 · Cited by 19
Alshorman, J., Mehran, M. J., Bahrami, Y., Mohammadzadeh, S., Barzigar, R., Morshedi, M., Haider, K. H., Tembo, K. M., Rong, S.-J., Jadgal, N., et al. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02107-5 · Cited by 22
“ML and DL algorithms have played a pivotal role in developing predictive models that inform risk stratification, prognosis, and therapeutic decisions( 233 ).”
Enhancing Nanomaterial-Based Optical Spectroscopic Detection of Cancer through Machine Learning
Sahli, C., & Kenry, K. (2024) · ACS Materials Letters · doi:10.1021/acsmaterialslett.4c01267 · Cited by 18
Han, Y. M., Sun, X., & Cai, S. (2025) · Biosensors · doi:10.3390/bios15060395 · Cited by 16
“Artificial intelligence (AI) refers to computational systems capable of performing tasks that typically require human intelligence, such as problem-solving and data analysis [91].”
Mondal, S., Preetam, S., Deshwal, R. K., Thapliyal, S., Rustagi, S., Alghamdi, S. A., Talukdar, N., Mishra, R., Bora, J., Banerjee, S., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120513 · Cited by 17
Bukke, S. P. N., Kumarachari, R. K., Rajasekhar, E. S. K., Jamal Basha, D., & Kamati, M. (2024) · Discover Sustainability · doi:10.1007/s43621-024-00575-x · Cited by 15
“These algorithms can analyze extensive datasets to detect patterns and make predictions that may elude human experts [18].”
Status of breast cancer detection in young women and potential of liquid biopsy
Stibbards-Lyle, M., Malinovska, J., Badawy, S., Schedin, P. S., & Rinker, K. D. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1398196 · Cited by 15
“Arti fi cial intelligence (AI) is expanding in use in existing imaging modalities and emerging detection tests (152).”
BackgroundTechnological Innovations and Multi-Omics Approaches in Cancer Research: A Comprehensive Review
Velmurugan, S., Wankhar, D., Paramasivan, V., & Subbaraj, G. K. (2025) · Biocell · doi:10.32604/biocell.2025.065891 · Cited by 13
Ahmad, I., Jasim, S. A., Sharma, M. K., Renuka Jyothi, S., Hjazi, A. M., Mohammed, J. S., Sinha, A., Zwamel, A. H., Hamzah, H. F., & Mohammed, B. A. (2024) · The Journal of Gene Medicine · doi:10.1002/jgm.3730 · Cited by 17
Recent Advances in Microfluidics for Nucleic Acid Analysis of Small Extracellular Vesicles in Cancer
Zhand, S., Goss, D. M., Cheng, Y. Y., & Warkiani, M. E. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401295 · Cited by 12
Artificial intelligence-assisted point-of-care devices for lung cancer
Ng, X. J. K., Khairuddin, A. S. M., Liu, H. L., Loh, T. C., Tan, J. L., Khor, S. M., & Leo, B. F. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120191 · Cited by 13
Firuzpour, F., Heydari, M., Aram, C., & Alishvandi, A. (2025) · Bioimpacts · doi:10.34172/bi.30984 · Cited by 27
“33 These AI systems can model how immune responses change in the presence of different therapeutic agents and help clinicians fine-tune dosages and schedules.”
Targeting extrachromosomal DNA in human cancers
Wong, I. T.-L., Yi, H., Melillo, B. N., Cravatt, B. F., Chang, H. Y., & Mischel, P. S. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01369-0 · Cited by 15
Advancing cancer care: How artificial intelligence is transforming oncology pharmacy
Alnuhait, M. A., Shahbar, A. N., Alrumaih, I. A., Alzahrani, T., Alzahrani, A. M., Alanizi, A. H., Alrashed, M. A., Elrggal, M. E., Alhuthali, A., & Alsuhebany, N. (2024) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2024.101529 · Cited by 14
Rabby, M. S., Islam, M. M., Kumar, S., Maniruzzaman, M., Hasan, M. A. M., Tomioka, Y., & Shin, J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317296 · Cited by 8
Shaukat, A., Farhan, S., Javed, R., Idris, S., Alamri, F. S., Ara, A., & Saba, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-22262-1 · Cited by 11
“Classical ML classifiers, including SVM, Random Forest, K-Nearest Neighbor (KNN), and Naïve Bayes, achieved accuracies up to 95.6% with 10-fold cross-validation 40 .”
InfluentialExosome-Machine Learning Integration in Biomedicine: Advancing Diagnosis and Biomarker Discovery
Kumar, R. M. R. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673319827240812052102 · Cited by 12
Karthiga, B., Praneeth, K. R., Saravanan, V., & Rao, T. K. R. K. (2025) · Egyptian Informatics Journal · doi:10.1016/j.eij.2025.100751 · Cited by 10
Min, J. H., Chen, P., Qureshi, T. A., Javed, S., Xie, Y., Azab, L., Wang, L., Kim, H., Li, D., & Yang, J. D. (2025) · Diagnostics · doi:10.3390/diagnostics15162090 · Cited by 10
Suri, C., Ratre, Y. K., Pande, B., Bhaskar, L. V., & Verma, H. K. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.v32.i1.111428 · Cited by 11
“ML algorithms have demonstrated significant potential in early cancer detection and diagnosis, offering unprecedented accuracy and efficiency across various domains of oncology[30].”
Naseer, F., Naseer, U., Yousaf, M., Wei, J., Gao, Y., Li, D., Tian, X., Liu, Y., Li, X., Wang, F., et al. (2026) · Sensors and Actuators Reports · doi:10.1016/j.snr.2026.100439 · Cited by 14
Recent Advances in AI and GenAI for Health Informatics
Ao, S. I., Palade, V., Holt, C., Araujo, S., Gourlay, M., & Kapetanovic, D. (2026) · Healthcare · doi:10.3390/healthcare14040495 · Cited by 13
“…are still very popular, especially for information processing purposes in the works of Al Kuwaiti et al. [84], Hossain et al. [100], Zhang et al. [108], Wang and Wang [109], Marques et al. [94], Chakraborty et al. [112], Gupta and Kumar [115], Ullah et al. [116], Armoundas et al. [117], Gupta et…”
Abu‐Khudir, R., Hafsa, N. E., & Badr, B. E. (2023) · Diagnostics · doi:10.3390/diagnostics13193091 · Cited by 10
The Role of Artificial Intelligence in Early Cancer Detection: Exploring Early Clinical Applications
Thaker, N. G., Dicker, A. P., Loaiza‐Bonilla, A., Wallace, A. F., Kolman, D., Ruggles, A. N. G., Manda, S., Frank, S. J., Orio, P. F., & Doria, C. (2024) · AI in Precision Oncology · doi:10.1089/aipo.2023.0011 · Cited by 15
“13,14 As natural language processing algorithms improve, electronic health record (EHR) data can be mined with AI tools to predict the likelihood of developing cancer based on a patient’s medical history, genetics, and lifestyle factors.”
Regulating Algorithmic HarmsPreprint
Lu, S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4949052 · Cited by 11
Epigenomic insights and computational advances in hematologic malignancies
Lauzon-Young, C., Silva, A., & Sadiković, B. (2025) · Molecular Cytogenetics · doi:10.1186/s13039-025-00712-9 · Cited by 11
“Additionally, AI methods such as support vector machines and neural networks contribute to precise risk stratification, diagnosis, and treatment outcome prediction, offering invaluable insights into HMs [88–90].”
Pranandi, I., & Tjhay, F. (2025) · International Journal of Computational and Experimental Science and Engineering · doi:10.22399/ijcesen.2634 · Cited by 13
Zhang, C., Zhu, K., Liu, J., & Yang, M. J. (2025) · Diseases · doi:10.3390/diseases13080271 · Cited by 10
“Machine learning and AI-driven approaches are useful tools and methods to predict the risk of obesity in cancer development and progression, and evaluate the treatment efficacy [176].”
Rajak, D., Nema, P., Sahu, A., Vishwakarma, S., & Kashaw, S. K. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.111120 · Cited by 12
Artificial intelligence‐assisted theranostics for brain tumors: Advancements and future perspectives
Li, M., Zhang, L., Ullah, Z., Zhang, Y., Wei, S., Huang, L., & Guo, B. (2025) · View · doi:10.1002/viw.20250119 · Cited by 9
Singh, J., Alsaidan, O. A., Aodah, A. H., Alrobaian, M., Almalki, W. H., Almujri, S. S., Sahoo, A., Alam, K., Lal, J. A., Barkat, M. A., et al. (2025) · Future Oncology · doi:10.1080/14796694.2025.2606642 · Cited by 6
Systems biology approaches for multi omics integration using artificial intelligence
Yadav, S., Mondal, J., & Saha, M. (2026) · Academia Biology · doi:10.20935/acadbiol8077 · Cited by 12
The Impact of Big Data Analytics on Health Care: A Systematic ReviewPreprint
Akour, I. A., & Salloum, S. A. (2024) · Research Square · doi:10.21203/rs.3.rs-4995748/v1 · Cited by 12
Random Forest based Risk Factor Analysis for Lung Cancer Prediction
Wiratama, R. K. P., Cahyadi, E. S., Meshcherekov, D., & Purwitasari, D. (2024) · International Conference on Smart Computing, IoT and Machine Learning (SIML) · doi:10.1109/siml61815.2024.10578224 · Cited by 8
“This decision is further supported by existing literature, which suggests that lifestyle choices, environmental exposures, and genetic predispositions play a more significant role in lung cancer development than age and gender alone [12].”
BackgroundMethodHarnessing machine learning for improved diagnosis, drug discovery, and patient care
Paul, J. K., Azmal, M., Talukder, O. F., Haque, A. S. N. B., Meem, M., & Ghosh, A. (2025) · Computational and Structural Biotechnology Reports · doi:10.1016/j.csbr.2025.100051 · Cited by 10
Basety, S., Gudepu, R., & Velidandi, A. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020201 · Cited by 10
Detrait, M. Y., Warnon, S., Lagasse, R., Dumont, L., Prophétis, S. D., Hansenne, A., Raedemaeker, J., Robin, V., Verstraete, G., Gillain, A., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311261 · Cited by 8
Personalized treatment strategies for breast adenoid cystic carcinoma: A machine learning approach
Alshwayyat, S., Hawa, M. B. A. A., Alshwayyat, M., Alshwayyat, T. A., sawan, S., Heilat, G. B., Hammouri, H., Mheid, S., Shweiat, B. A., & Hanifa, H. (2025) · The Breast · doi:10.1016/j.breast.2025.103878 · Cited by 8
Barr, C. J. S., Erdélyi, O. J., Docherty, P. D., & Grace, R. C. (2024) · arXiv (Cornell University) · doi:10.48550/arxiv.2411.06624 · Cited by 11
“Recently, the progression of AI and improved societal trust have enabled its use in more high-risk scenarios, such as autonomous driving [5], piloting fighter jets [6], and identifying cancer cells [7], [8].”
Challenges in the future of cancer screening
Lynge, E., Andersen, B. S., Bojesen, S. E., Petersen, L. K., Bech, M., Bøgsted, M., Dam, M. S., Egstrand, S., Hvass, A. M. F., Kobylecki, C. J., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70286 · Cited by 8
“26 For a comprehensive review of new technologies in cervical screening, see Zhang et al. 27 FIGURE 1 Age-standardized rates (Nordic standard population) per 100,000 of incidence (upper, blue line) and mortality (lower, red line) of cervical and breast in women, and colorectal cancer in men and women in Denmark 1965 t…”
A 4‐gene prognostic index for enhancing acute myeloid leukaemia survival prediction
Rojas, C. A. O., Pereira‐Martins, D. A., More, C. B., Sternadt, D., Weinhäuser, I., Hilberink, J. R., Coelho‐Silva, J. L., Thomé, C. H., Ferreira, G. A., Ammatuna, E., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19472 · Cited by 8
Cilla, S., Rossi, R., Habberstad, R. H., Klepstad, P., Dall’Agata, M., Kaasa, S., Valenti, V., Donati, C. M., Maltoni, M. C., & MORGANTI, A. G. (2024) · JCO Clinical Cancer Informatics · doi:10.1200/cci.24.00027 · Cited by 7
“3,4 However, palliative care has remained largely unaffected by ML developments, 5 and only two ML models for prognostication after palliative RT are previously reported.”
Artificial-Intelligence-Driven Precision Medicine in Cancer Treatment
Hassane, M. (2024) · Premier journal of science. · doi:10.70389/pjs.100041 · Cited by 8
Valero-Ramón, Z., Ibáñez-Sánchez, G., Martínez-Millana, A., & Fernández-Llatas, C. (2025) · Sensors · doi:10.3390/s25072097 · Cited by 7
“[45] explores AI technologies in cancer prediction, noting that most research has prioritised improving diagnosis and prognosis through traditional medical histories.”
Jiang, Z., Low, J., Huang, K. C., Yue, Y., Njeh, C. F., & Oderinde, O. M. (2025) · Medical Oncology · doi:10.1007/s12032-025-02982-0 · Cited by 7
“For instance, studies by Cai et al. and Zhang et al. have demonstrated that radiomic features extracted from imaging data can serve as valuable predictors of treatment response in various cancers [9, 27].”
Raghu, A., Raghu, A., & Wise, J. F. (2024) · JMIR Bioinformatics and Biotechnology · doi:10.2196/56538 · Cited by 8
“Machine learning implementations have increased accuracy in predicting cancer and have the potential to improve the diagnosis, prognosis, and therapy selection for patients with cancer [15].”
BackgroundRösler, W., Roiss, M., & Widmer, C. (2024) · healthbook TIMES Oncology Hematology · doi:10.36000/hbt.oh.2024.20.146 · Cited by 7
Velásquez-Sotomayor, M., Segura, A. V. C., Montalva, R., Marín-Sánchez, O., Carrasco, A. G. M., & Rojas, C. A. O. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1206609 · Cited by 7
Navigating the unseen peril: safeguarding medical imaging in the age of AI
Maertens, A., Brykman, S., Härtung, T., Gafita, A., Bai, H. X., Hoelzer, D., Skoudis, E., & Paller, C. J. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1400732 · Cited by 6
Rashid, H., Acharya, S., Muhammad, H., & Aziz, M. A. (2025) · 3 Biotech · doi:10.1007/s13205-025-04362-x · Cited by 7
“Machine learning (ML), a branch of AI, has proven particularly effective in predicting various cancers—such as breast, brain, lung, liver, and prostate— often surpassing the accuracy of human clinicians (Zhang et al. 2023).”
Metadata
- Authors
- Zhang, B., Shi, H., & Wang, H.
- Affiliations
- Tonghua Normal University (CN)
- Corresponding author
- Zhang, Bo
- Venue
- Journal of Multidisciplinary Healthcare
- Publisher
- Informa UK Limited
- Published
- 2023-06
- Volume
- Volume 16
- Pages
- 1779-1791
- ISSN
- 1178-2390 (ISSN-L)
- PMC
- PMC10312208
- OpenAlex
- W4381989081
- Cited by
- 347
- References
- 89
- Citations by year
- 2026: 102 · 2025: 152 · 2024: 80 · 2023: 13
- FWCI
- 7.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Multidisciplinary Healthcare (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- artificial intelligence, machine learning, cancer prognosis, cancer prediction, treatment selection, cancer risk assessment, early cancer detection, breast cancer, brain cancer, lung cancer, liver cancer, prostate cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.